Abzena provides technologies and complementary services

Abzena provides proprietary technologies and complementary services to organisations involved in the development of biopharmaceutical products.

Working with companies and academic groups all over the world, including most of the top 20 biopharmaceutical companies, Abzena supports the development and manufacture of better treatments for patients.

Eleven antibodies which have been created using Abzena’s technologies are currently being progressed through clinical development.

Read more

Latest Events

31 October 2016
PEGS Europe
7 November 2016
Bio-Europe 2016
14 November 2016
European Antibody Congress
16 November 2016
Immune Checkpoint Inhibitors, Europe
5 December 2016
Bispecifics: From Discovery to first in human

View More Events

Share Price


Abzena's Service and Technology Brochure

This brochure contains an overview of Abzena's range of services from discovery to GMP manufacturing. Abzena Brochure

Interested in our services? Get In Touch